Results 51 to 60 of about 913,703 (307)

Serious adverse events associated with yellow fever vaccine [PDF]

Human Vaccines & Immunotherapeutics, 2015
Yellow fever vaccine was considered one of the safest vaccines, but in recent years it was found that it could rarely cause invasive and disseminated disease in some otherwise healthy individuals, with high lethality. After extensive studies, although some risk factors have been identified, the real cause of causes of this serious adverse event are ...
de Menezes Martins, Reinaldo, da Luz Fernandes Leal, Maria, Homma, Akira   +2 more
openaire   +2 more sources

Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. [PDF]

, 2018
BACKGROUND: Epidemiological evidence has suggested a link between use of beta₂-agonists and increased asthma mortality. Much debate has surrounded possible causal links for this association, and whether regular (daily) long-acting beta₂-agonists (LABAs ...
Adinoff, Adolfsson, Altman, Anderson, Anonymous, Arnold, Arthurs, Aubier, Bailey, Barnes, Barnes, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Bateman, Baumgarten, Beach, Bennett, Berg, Bernstein, Bijl-Hofland, Bjermer, Bjermer, Bleecker, Bleecker, Bleecker, Bons, Boushey, Boushey, Bousquet, Bousquet, Bousquet, Bousquet, Bracamonte, Briggs, Burgess, Busse, Calhoun, Casale, Casale, Casale, Casale, Casale, Casale, Castle, Cates, Cates, Cates, Cates, Cates, Cates, Cates, Cates, Clark, Clark, Clark, Clark, Cockcroft, Collins, Condemi, Cook, Cordier, Crane, D'Urzo, Deykin, Didier, Dorinsky, Ducharme, Edin, Fish, Fujimoto, Giembycz, Godard, Godard, Gordon, Grainger, Greening, Greenstone, Grutters, Guhan, Hanania, Hancox, Hancox, Haney, Harvey, House, Ilowite, Ind, Isabelle, Ismaila, Jaeschke, Jaeschke, Janssen, Jarjour, Jones, Juniper, Katial, Katial, Kavuru, Kelsen, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerstjens, Kerwin, Kerwin, Koenig, Koopmans, Lawrence, Lazarus, Lee, Lemanske, Lenney, Li, Lipworth, Lipworth, Lipworth, Lipworth, Lundback, Lundbäck, Lötvall, Lötvall, Malone, Mansfield, Martinat, McDevitt, McIvor, Morrison, Murray, Nan, Nathan, Nathan, Nelson, Nelson, Nelson, Nelson, Ni Chroinin, Ni Chroinin, Noord, Noord, O'Connor, Palmqvist, Pauwels, Pauwels, Pauwels, Pearce, Pearce, Pearlman, Pearlman, Pearlman, Pedersen, Peters, Peters, Ploszczuk, Ploszczuk, Prazma, Raphael, Reddel, Ringdal, Rojas, Rooklin, Rosenthal, Russell, Salpeter, Schlosser, Scott, Sears, Sears, Shapiro, Sher, Slankard, Slankard, Speizer, Stempel, Stempel, Stempel, Strand, Sweeting, Tonnel, vanNoord, Vermetten, Wallin, Walters, Walters, Weber, Weinstein, Weiss, Wilson, Wong, Woolcock, Woude, Yates, You-Ning, You-Ning, Zhong, Zhong   +202 more
core   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle, Kiersten Ricci, Kelly Blache, Rebecca A. Marsh, Adrienne M. Hammill, Elissa Engel   +5 more
wiley   +1 more source

Interventions for necrotising pancreatitis [PDF]

, 2016
BACKGROUND: Acute necrotising pancreatitis carries significant mortality, morbidity, and resource use. There is considerable uncertainty as to how people with necrotising pancreatitis should be treated.
Belgaumkar, AP, Davidson, BR, Gurusamy, KS, Haswell, A, Pereira, SP   +4 more
core   +1 more source

Feasibility and Safety of High‐Dose Proton Re‐Irradiation in Recurrent Pediatric Central Nervous System Tumors: A Single‐Institution Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Pediatric central nervous system (CNS) tumors often recur despite multimodality therapy. Although re‐irradiation (re‐RT) has historically been limited by concerns for severe late toxicities, modern techniques have renewed interest in this approach. Proton therapy provides dosimetric advantages that may enable curative re‐treatment with
Jin‐Ho Song, Jonathan Baron, Carlos Chavez Perez, Sidharth Ramesh, Jane Minturn, Kavita A. Desai, Amish C. Shah, Jean M. Belasco, Kristina A. Cole, Michael J. Fisher, Phillip B. Storm, Peter M. Madsen, Goldie Kurtz, Robert A. Lustig, Christine Hill‐Kayser, Michael J. LaRiviere   +15 more
wiley   +1 more source

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

Polypectomy Techniques, Endoscopist Characteristics, and Serious Gastrointestinal Adverse Events [PDF]

, 2014
Background: A use of polypectomy techniques by endoscopist specialty (primary care, surgery, and gastroenterology) and experience (volume), and associations with serious gastrointestinal adverse events, were examined.
BouHaidar, Doumit, Bradley, Cathy J., Chukmaitov, Askar S., Dahman, Bassam, Siangphoe, Umaporn, Warren, Joan L.   +5 more
core   +2 more sources

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

Molecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli, Alessio Bevilacqua, Mathias Wenes, Denis Migliorini, Lars van der Veen, Sigrid S Skånland, Giusy Di Conza, Kjetil Taskén   +7 more
wiley   +1 more source

Analysis of Adverse Events Associated With Dental Local Anaesthetics Using Food and Drug Administration Adverse Event Reporting System Data

International Dental Journal
Objective: Local anaesthetics (LAs), almost indispensable aspect of dental practice for pain-free procedures, occasionally leads to worrisome adverse events (AEs).
Ferit Bayram, Ahmet Akici, Asli Melda Apari, Volkan Aydin   +3 more
doaj   +1 more source